DENTSPLY SIRONA (NASDAQ:XRAY) Releases FY 2026 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) updated its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 1.200-1.300 for the period, compared to the consensus estimate of 1.470. The company issued revenue guidance of $3.5 billion, compared to the consensus revenue estimate of $3.6 billion.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Leerink Partners cut their target price on DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating on the stock in a report on Wednesday, October 14th. Weiss Ratings reiterated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Friday, October 30th. Mizuho reduced their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Thursday, October 22nd. BMO Capital Markets dropped their price target on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a research report on Thursday, September 17th. Finally, Piper Sandler cut their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Friday, October 9th. Three analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $12.62.

DENTSPLY SIRONA Trading Down 5.5%

Shares of DENTSPLY SIRONA stock traded down $0.59 on Thursday, hitting $10.06. 5,030,676 shares of the company’s stock traded hands, compared to its average volume of 4,890,916. The firm’s 50-day moving average price is $9.65 and its two-hundred day moving average price is $11.30. The stock has a market capitalization of $2.01 billion, a PE ratio of -3.66, a price-to-earnings-growth ratio of 1.25 and a beta of 0.87. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.63 and a quick ratio of 1.07. DENTSPLY SIRONA has a one year low of $8.32 and a one year high of $14.76.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.17. The firm had revenue of $898.00 million for the quarter, compared to analysts’ expectations of $889.93 million. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%. The company’s revenue was down 4.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.52 earnings per share. On average, research analysts expect that DENTSPLY SIRONA will post 1.39 EPS for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.